{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:14:58Z","timestamp":1786990498550,"version":"build-2736575974"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["DUT24YG153"],"award-info":[{"award-number":["DUT24YG153"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["DUT23YG125"],"award-info":[{"award-number":["DUT23YG125"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273778"],"award-info":[{"award-number":["82273778"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82270186"],"award-info":[{"award-number":["82270186"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.ijbiomac.2025.143249","type":"journal-article","created":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T12:17:09Z","timestamp":1744805829000},"page":"143249","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"P3","title":["A kinase-independent Bcr-Abl function mediating an Hsp70-Bim protein-protein interaction in chronic myeloid leukemia"],"prefix":"10.1016","volume":"310","author":[{"given":"Hong","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyuan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud E.S.","family":"Soliman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maojun","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangkui","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zixuan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziqian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhichao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2025.143249_bb0005","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1073\/pnas.0510423103","article-title":"Gene expression changes associated with progression and response in chronic myeloid leukemia","volume":"103","author":"Radich","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijbiomac.2025.143249_bb0010","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/nrm1280","article-title":"Regulation of the c-Abl and Bcr-Abl tyrosine kinases","volume":"5","author":"Hantschel","year":"2004","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ijbiomac.2025.143249_bb0015","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1056\/NEJM200104053441409","article-title":"Targeting the BCR-ABL tyrosine kinase in chronic myeloid leukemia","volume":"344","author":"Goldman","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijbiomac.2025.143249_bb0020","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1056\/NEJMoa062867","article-title":"Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia","volume":"355","author":"Druker","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijbiomac.2025.143249_bb0025","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1182\/blood-2007-03-066936","article-title":"Bcr-Abl kinase domain mutations, drug resistance, and the road to a cure for chronic myeloid leukemia","volume":"110","author":"O\u2019Hare","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.ijbiomac.2025.143249_bb0030","doi-asserted-by":"crossref","first-page":"347","DOI":"10.3324\/haematol.2010.039560","article-title":"Mutant BCR-ABL clones in chronic myeloid leukemia","volume":"96","author":"Mathisen","year":"2011","journal-title":"Haematologica"},{"key":"10.1016\/j.ijbiomac.2025.143249_bb0035","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1038\/sj.leu.2402741","article-title":"Molecular and chromosomal mechanisms of resistance to imatinib (STI571) therapy","volume":"16","author":"Hochhaus","year":"2002","journal-title":"Leukemia"},{"key":"10.1016\/j.ijbiomac.2025.143249_bb0040","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1182\/blood.V99.1.319","article-title":"Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in vitro","volume":"99","author":"Graham","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.ijbiomac.2025.143249_bb0045","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1146\/annurev.immunol.22.012703.104753","article-title":"The BCR-ABL story: bench to bedside and back","volume":"22","author":"Wong","year":"2004","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.ijbiomac.2025.143249_bb0050","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/nrclinonc.2016.139","article-title":"Tyrosine kinase inhibitors in chronic myeloid leukaemia: which, when, for whom?","volume":"14","author":"Rosti","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.ijbiomac.2025.143249_bb0055","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1056\/NEJMoa1306494","article-title":"A phase 2 trial of ponatinib in Philadelphia chromosome-positive leukemias","volume":"369","author":"Cortes","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijbiomac.2025.143249_bb0060","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3009073","article-title":"A therapeutically targetable mechanism of BCR-ABL-independent imatinib resistance in chronic myeloid leukemia","volume":"6","author":"Ma","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ijbiomac.2025.143249_bb0065","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1038\/s41375-020-01037-9","article-title":"Declaration of Bcr-Abl independence","volume":"34","author":"Zhao","year":"2020","journal-title":"Leukemia"},{"key":"10.1016\/j.ijbiomac.2025.143249_bb0070","doi-asserted-by":"crossref","first-page":"3358","DOI":"10.1200\/JCO.2007.15.8154","article-title":"Imatinib for newly diagnosed patients with chronic myeloid leukemia: incidence of sustained responses in an intention-to-treat analysis","volume":"26","author":"de Lavallade","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ijbiomac.2025.143249_bb0075","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.apsb.2011.10.007","article-title":"Mechanisms of acquired resistance to tyrosine kinase inhibitors","volume":"14","author":"Chen","year":"2011","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ijbiomac.2025.143249_bb0080","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1021\/acs.jmedchem.1c01978","article-title":"Targeting the non-catalytic functions: a new paradigm for kinase drug discovery?","volume":"65","author":"Wang","year":"2022","journal-title":"J. Med. Chem."},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.143249_bb0085","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1038\/s41375-024-02365-w","article-title":"BCR-ABL1 proteolysis-targeting chimeras (PROTACs): the new frontier in the treatment of Ph+ leukemias?","volume":"38","author":"Cruz-Rodriguez","year":"2024","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.143249_bb0090","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/s41392-021-00826-7","article-title":"An overview of kinase downregulators and recent advances in discovery approaches","volume":"6","author":"Wang","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.ijbiomac.2025.143249_bb0095","doi-asserted-by":"crossref","first-page":"3260","DOI":"10.1182\/blood-2013-04-497040","article-title":"BCR-ABL1 promotes leukemia by converting p27 into a cytoplasmic oncoprotein","volume":"124","author":"Agarwal","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.ijbiomac.2025.143249_bb0100","doi-asserted-by":"crossref","first-page":"4144","DOI":"10.1172\/JCI68951","article-title":"PP2A-activating drugs selectively eradicate TKI-resistant chronic myeloid leukemic stem cells","volume":"123","author":"Neviani","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ijbiomac.2025.143249_bb0105","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.ccell.2020.03.006","article-title":"Response and resistance to BCR-ABL1-targeted therapies","volume":"37","author":"Braun","year":"2020","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ijbiomac.2025.143249_bb0110","doi-asserted-by":"crossref","first-page":"405","DOI":"10.5966\/sctm.2012-0159","article-title":"Kinase-independent mechanisms of resistance of leukemia stem cells to tyrosine kinase inhibitors","volume":"3","author":"Ichim","year":"2014","journal-title":"Stem Cells Transl. Med."},{"key":"10.1016\/j.ijbiomac.2025.143249_bb0115","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/nrc1567","article-title":"Mechanisms of BCR\u2013ABL in the pathogenesis of chronic myelogenous leukaemia","volume":"5","author":"Ren","year":"2005","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ijbiomac.2025.143249_bb0120","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12964-021-00752-9","article-title":"Effect of HSP90AB1 and CC domain interaction on Bcr-Abl protein cytoplasm localization and function in chronic myeloid leukemia cells","volume":"19","author":"Peng","year":"2021","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.ijbiomac.2025.143249_bb0125","doi-asserted-by":"crossref","first-page":"4744","DOI":"10.1158\/0008-5472.CAN-19-1236","article-title":"Targeting BCR-ABL1 in chronic myeloid leukemia by PROTAC-mediated targeted protein degradation","volume":"79","author":"Burslem","year":"2019","journal-title":"Cancer Res."},{"key":"10.1016\/j.ijbiomac.2025.143249_bb0130","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1093\/carcin\/bgt111","article-title":"The HSP70 family and cancer","volume":"34","author":"Murphy","year":"2013","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.ijbiomac.2025.143249_bb0135","doi-asserted-by":"crossref","first-page":"4153","DOI":"10.1038\/onc.2014.349","article-title":"Hsp70 in cancer: back to the future","volume":"34","author":"Sherman","year":"2015","journal-title":"Oncogene"},{"key":"10.1016\/j.ijbiomac.2025.143249_bb0140","doi-asserted-by":"crossref","first-page":"4731","DOI":"10.1158\/0008-5472.CAN-14-0747","article-title":"Hsp70-Bag3 interactions regulate cancer-related signaling networks","volume":"74","author":"Colvin","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.ijbiomac.2025.143249_bb0145","doi-asserted-by":"crossref","first-page":"12900","DOI":"10.1074\/jbc.RA120.013364","article-title":"The chaperone Hsp70 is a BH3 receptor activated by the pro-apoptotic Bim to stabilize anti-apoptotic clients","volume":"295","author":"Guo","year":"2020","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2025.143249_bb0150","doi-asserted-by":"crossref","first-page":"2862","DOI":"10.1038\/s41375-021-01283-5","article-title":"Small-molecule inhibitor targeting the Hsp70-Bim protein-protein interaction in CML cells overcomes BCR-ABL-independent TKI resistance","volume":"35","author":"Song","year":"2021","journal-title":"Leukemia"},{"key":"10.1016\/j.ijbiomac.2025.143249_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113645","article-title":"Discovery of novel BCR-ABL PROTACs based on the cereblon E3 ligase design, synthesis, and biological evaluation","volume":"223","author":"Liu","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2025.143249_bb0160","doi-asserted-by":"crossref","first-page":"16377","DOI":"10.1021\/acs.jmedchem.3c01783","article-title":"Exploiting the \u201chot-spots\u201d of Hsp70-Bim protein-protein interaction to optimize the 1-Oxo-1H-phenalene-2,3-dicarbonitrile analogues as specific Hsp70-Bim inhibitors","volume":"66","author":"Wang","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2025.143249_bb0165","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/sj.leu.2402778","article-title":"The interaction of the Bcr-Abl tyrosine kinase with the Src kinase Hck is mediated by multiple binding domains","volume":"17","author":"Stanglmaier","year":"2003","journal-title":"Leukemia"},{"key":"10.1016\/j.ijbiomac.2025.143249_bb0170","doi-asserted-by":"crossref","first-page":"33260","DOI":"10.1074\/jbc.272.52.33260","article-title":"The Src family kinase Hck interacts with Bcr-Abl by a kinase-independent mechanism and phosphorylates the Grb2-binding site of Bcr","volume":"272","author":"Warmuth","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2025.143249_bb0175","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1002\/j.1460-2075.1993.tb05797.x","article-title":"An actin-binding function contributes to transformation by the Bcr-Abl oncoprotein of Philadelphia chromosome-positive human leukemias","volume":"12","author":"McWhirter","year":"1993","journal-title":"EMBO J."},{"key":"10.1016\/j.ijbiomac.2025.143249_bb0180","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1016\/j.febslet.2015.07.037","article-title":"Cell surface localised Hsp70 is a cancer specific regulator of clathrin-independent endocytosis","volume":"589","author":"Nimmervoll","year":"2015","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ijbiomac.2025.143249_bb0185","doi-asserted-by":"crossref","first-page":"4535","DOI":"10.1128\/MCB.19.6.4535","article-title":"Identification of CHIP, a novel tetratricopeptide repeat-containing protein that interacts with heat shock proteins and negatively regulates chaperone functions","volume":"19","author":"Ballinger","year":"1999","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.ijbiomac.2025.143249_bb0190","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1182\/blood-2004-05-2041","article-title":"Mechanistic role of heat shock protein 70 in Bcr-Abl\u2013mediated resistance to apoptosis in human acute leukemia cells","volume":"105","author":"Guo","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.ijbiomac.2025.143249_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.114964","article-title":"Bcr-Abl drives the formation of Hsp70\/Bim PPI to stabilize oncogenic clients and prevent cells from undergoing apoptosis","volume":"198","author":"Zhang","year":"2022","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2025.143249_bb0200","doi-asserted-by":"crossref","first-page":"939","DOI":"10.3389\/fonc.2019.00939","article-title":"BCR-ABL independent mechanisms of resistance in chronic myeloid leukemia","volume":"9","author":"Loscocco","year":"2019","journal-title":"Front. Oncol."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.143249_bb0205","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1007\/s12185-021-03126-6","article-title":"Target spectrum of the BCR-ABL tyrosine kinase inhibitors in chronic myeloid leukemia","volume":"113","author":"Lee","year":"2021","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.ijbiomac.2025.143249_bb0210","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.tibs.2013.08.001","article-title":"Hsp70 chaperone dynamics and molecular mechanism","volume":"38","author":"Mayer","year":"2013","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.ijbiomac.2025.143249_bb0215","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.canlet.2015.02.026","article-title":"The role of heat shock proteins in cancer","volume":"360","author":"Lianos","year":"2015","journal-title":"Cancer Lett."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025038012?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025038012?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T10:47:08Z","timestamp":1782902828000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813025038012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":43,"alternative-id":["S0141813025038012"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.143249","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A kinase-independent Bcr-Abl function mediating an Hsp70-Bim protein-protein interaction in chronic myeloid leukemia","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.143249","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"143249"}}